Mast cell modulation of tumour cell proliferation in rat mammary adenocarcinoma 13762NF
- PMID: 2069844
- PMCID: PMC1972547
- DOI: 10.1038/bjc.1991.192
Mast cell modulation of tumour cell proliferation in rat mammary adenocarcinoma 13762NF
Abstract
Mast cells were shown to accumulate around the periphery of the invasive and metastatic rat mammary adenocarcinoma (MTLn3), and histological evidence of mast cell degranulation was observed during the later stages of this model. To assess the physiological role of mast cells in vivo we have used the mast cell-stabilising compound FPL 55618 applied i.p. daily at 1 mg kg-1 for 23 days. Using groups of 12 rats we have found that this compound inhibited tumour growth at the primary site by as much as 70% in most of the treated animals compared with the control group which received equivalent volumes of saline. When the drug treatment was stopped after 23 days, tumour growth of the test group accelerated over the next 7 days and reached a similar tumour size to that of control animals. Histological studies of the tumour and contiguous host tissue at day 24 of the experiment revealed numerous extra-tumoural mast cells often showing signs of degranulation at several sites around the tumour periphery in the control animals. Such observations were not seen in those animals receiving FPL 55618 where, in contrast to controls, numerous intact mast cells were often seen within the tumour mass. Following cessation of the MC-stabilising treatment progressive mast cell activation was evident within 2-4 days, primarily at the tumour periphery. In vitro studies have shown that drug concentrations equivalent to five times the in vivo dose had no effect on the proliferative rate or viability of the MTLn3 cells. Moreover, the proliferative rate of these cells in culture was significantly increased when exposed to soluble mast cell products. Thus our data indicate that a mast cell-stabilising compound has significant benefits in reducing tumour growth in vivo, an observation which supports the concept that mast cell:tumour cell interactions are important for the growth and invasive properties demonstrated by this model of breast carcinoma.
Similar articles
-
Mast cells and matrix degradation at sites of tumour invasion in rat mammary adenocarcinoma.Br J Cancer. 1986 Sep;54(3):459-65. doi: 10.1038/bjc.1986.198. Br J Cancer. 1986. PMID: 3019377 Free PMC article.
-
The nature and significance of tumour-associated mast cells.J Pathol. 1986 Feb;148(2):175-82. doi: 10.1002/path.1711480208. J Pathol. 1986. PMID: 3950814
-
Effect of host immune status on the spontaneous metastasis of cloned cell lines of the 13762NF rat mammary adenocarcinoma.Br J Cancer. 1985 Nov;52(5):747-55. doi: 10.1038/bjc.1985.253. Br J Cancer. 1985. PMID: 4063149 Free PMC article.
-
Mast cell-tumour cell interactions: matrix degradation and the demonstration of histamine H2 receptors on human melanoma.Adv Exp Med Biol. 1988;233:81-90. doi: 10.1007/978-1-4899-5037-6_10. Adv Exp Med Biol. 1988. PMID: 3066159 Review. No abstract available.
-
Mast cell-tumor cell interactions: for or against tumour growth and metastasis?Anticancer Res. 1997 May-Jun;17(3A):1541-9. Anticancer Res. 1997. PMID: 9179193 Review.
Cited by
-
Tumor microenvironment: a main actor in the metastasis process.Clin Exp Metastasis. 2012 Apr;29(4):381-95. doi: 10.1007/s10585-012-9457-5. Epub 2012 Feb 10. Clin Exp Metastasis. 2012. PMID: 22322279 Review.
-
Biomarkers of metastatic potential in cultured adenocarcinoma clones.Clin Exp Metastasis. 2011 Feb;28(2):101-11. doi: 10.1007/s10585-010-9362-8. Epub 2010 Nov 23. Clin Exp Metastasis. 2011. PMID: 21104427
-
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis.Genes Dev. 1999 Jun 1;13(11):1382-97. doi: 10.1101/gad.13.11.1382. Genes Dev. 1999. PMID: 10364156 Free PMC article.
-
Mast cells and the neurofibroma microenvironment.Blood. 2010 Jul 15;116(2):157-64. doi: 10.1182/blood-2009-09-242875. Epub 2010 Mar 16. Blood. 2010. PMID: 20233971 Free PMC article. Review.
-
Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells.Blood. 2008 Dec 1;112(12):4646-54. doi: 10.1182/blood-2008-04-155085. Epub 2008 Sep 2. Blood. 2008. PMID: 18768391 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources